Main Data: 31/12 Year 2016
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions / Euro
- total revenues 1,310.85
- industrial gross profit 480.59
- total operating cost 339.25
- operating profit 141.34
- net financial income 6.28
- profit attributable to equity holders of the parent 93.54
   
Consolidated balance sheet Millions / Euro
- working capital 3.42
- non-current assets 446.96
- provision for severance indemnities and other provisions

-80.26

- net debt -99.94
- equity pertaining to the group and minority interests 270.18
   
Other information Millions / Euro
- depreciation, amortization and impairment 39.55
- R & D costs 48.15
   
  Euro
Dividend per share 1.40
   
  No.
Employees 5,109
   
  Euro
Share capital 20,415,200



Main Data: 30/06 Year 2016
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions / Euro
- total revenues 572.2
- gross industrial income 214.7
- total operating cost 169.9
- operating profit 44.8
- net financial income 13.1
- profit attributable to equity holders of the parent  39.4
   
Consolidated balance sheet Millions / Euro
- working capital 41.4
- non-current assets 434.9
- provision for severance indemnities and other provisions -80.8
- net debt -188.9
- equity pertaining to the group and minority interests 206.6
   
Other information Millions / Euro
- depreciation, amortization and impairment 18.3
- R & D costs 23.6
   
  No.
Employees 4,962
   
  Euro
Share capital 20,415,200


Net Sales By Sector: Year 2016
  Millions/Euro  
tea, food & other 757.42 57.8%
pharmaceutical 553.43 42.2%
     
Total 1,310.85 100.0%



Net Sales by Country: Year 2016
  Millions/Euro  
E.U. (excluding Italy) 395.45 30.2%
Other European countries 97.33 7.4%
North America 218.69 16.7%
Asia & Middle East 294.65 22.5%
Other countries 128.63 9.8%
Total exports 1,134.75 86.6%
Italy 176.10 13.4%
     
Total 1,310.85 100.0%